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Abstract. Ran/TC4, first identified as a well-conserved 
gene distantly related to H-RAS, encodes a protein 
which has recently been shown in yeast and mam- 
malian systems to interact with RCC1, a protein whose 
function is required for the normal coupling of the 
completion of DNA synthesis and the initiation of mi- 
tosis. Here, we present data indicating that the nuclear 
localization of Ran/TC4 requires the presence of 
RCC1.  Transient expression of a  Ran/TC4 protein with 
mutations expected to perturb GTP hydrolysis disrupts 
host cell DNA synthesis. These results suggest that 
Ran/TC4 and RCC1 are components of a  GTPase 
switch that monitors the progress of DNA synthesis 
and couples the completion of DNA synthesis to the 
onset of mitosis. 
AN/TC4, was initially described as a RAS-related tran- 
script of unknown function. It was  identified in a 
human teratocarcinoma cell line but is abundant in a 
variety of cultured cell lines, and is of interest because it 
defines a new, evolutionarily well-conserved branch of the 
RAS gene superfamily (Drivas et al.,  1990, 1991a).  Recent 
genetic and biochemical analyses (Matsumoto and Beach, 
1991; Bischoff and Ponstingl, 1991a) suggest that Ran/TC4 
also plays a key role in the regulation of cell cycle progres- 
sion in eukaryotes, and that this role depends on its nuclear 
localization and interaction with the product of a  second 
gene, RCC1, defined by the tsBN2 mutation of BHK cells 
(Nishimoto et al., 1978; Uchida et al.,  1990) and the piml 
mutation of the fission yeast Schizosaccharomyces pombe 
(Matsumoto and Beach,  1991). The compound name used 
here reflects this:  a  teratocarcinoma-derived eDNA clone 
that encodes a Ras-related nuclear (Ran) protein. 
S. pombe piml (premature initiation of mitosis) mutants 
enter mitosis without completing chromosomal DNA repli- 
cation. Overexpression of the wild-type allele of a second 
gene, spil (suppressor ofpiml),  suppresses the piml mutant 
phenotype.  The  predicted  amino  acid  sequences  of spil 
(yeast) and Ran/TC4 (human) are 80%  identical. The fact 
that spil overexpression cannot rescue null mutants and the 
existence of a cold-sensitive mutation in spil suggest direct 
interaction between Piml and Spil proteins (Matsumoto and 
Beach,  1991). 
The mammalian homolog of piml is RCC1 (regulator of 
chromosomal condensation), a gene originally defined by the 
tsBN2 mutation of BHK cells (Uchida et al., 1990; Nishitani 
et al., 1991). The wild-type activity of RCC1 is required both 
to initiate DNA synthesis (Dasso et al., 1992) and to prevent 
chromosome condensation until the completion of S phase 
(Uchida et al.,  1990;  Nishitani et al.,  1991; Enoch and 
Nurse, 1991; Dasso and Newport,  1990). piml is predicted 
to encode a larger protein (539 aa) than RCC1 (421 aa), but 
over the region shared by the two proteins, their sequences 
are 30 % identical and share a sequence motif  repeated seven 
times in each protein (Matsumoto and Beach,  1991). 
RCC1 protein can bind DNA and is associated with chro- 
matin (Ohtsubo et al.,  1989).  It is present in Xenopus egg 
extracts in amounts sufficient to provide one molecule per 
nucleosome (Dasso et al.,  1992),  and can be purified from 
HeLa cell chromatin in the form of a complex with a 25-kD 
protein. Partial amino acid sequence data indicate that the 
latter is Ran/TC4 (Bischoff et al.,  1990;  Bischoff and Pon- 
stingl,  1991a). 
To further characterize the function of Ran/TC4 and its in- 
teraction with RCC1 in mammalian cells, we have now pre- 
pared Ran/TC4-specific antibodies and used them to demon- 
strate that nuclear localization of Ran/TC4 is dependent on 
expression of RCC1. We have also shown that expression of 
a mutant Ran/TC4 allele blocks cellular DNA replication. 
Materials and Methods 
DNA Sequencing and In Vitro Mutagenesis 
DNA sequencing was performed as described previously (Drivas et al., 
1990,  1991b)  using double-stranded pMT2  or lambda phage templates, 
with Ran/TC4-specific oligonucleotides as primers. 
In vitro mutagenesis was performed by oligonucleotide priming, using 
the 1.5-kb Ran/TC4 eDNA EcoRI fragment (Drivas et al.,  1990) cloned 
in M13 as a template. Mutants were identified by differential hybridization 
with wild-type and variant oligonucleotide probes, and the mutated EcoRI 
fragments were isolated and cloned into the EcoRI site of pMT2. Mutant 
identifications were confirmed by DNA sequence analysis of  both the initial 
M13 isolate and the pMT2 subclones. 
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The dodecapeptide  underlined  in Fig.  1 was synthesized,  coupled with 
glutaraidehyde  to Keyhole Limpet  hemocyanin,  emulsified in complete 
Freund's  adjuvant,  and  injected  intradermally  into two rabbits  (Pocono 
Rabbit Farms).  One yielded a high-titer polyclonai antiserum used in all 
experiments described here. RCC1 antibody (Nishitani et al.,  1991) was 
a generous gift of Dr. Takeharo Nishimoto. 
Cell Lines 
tsBN2 cells were a generous gift from Dr. Claudio Basilico. HeLa, COS, 
3T3, and wild-type BHK21 hamster cells were from laboratory stocks de- 
rived ultimately from American Type Culture Collection, Rockville, MD. 
lmmunoblotting 
Total CellLysates. Cells at 50-75 % confluence in 10-cm dishes were lysed 
in 0.5 mi of 2% SDS, 50 mM Tris, pH 7.5, boiled for 10 rain, sonicated, 
and added to an equal volume of  4% SDS, 0.05% Bromophenol blue, 40% 
glycerol,  10% ~-mereapteothanol, 200 mM Tris, pH 6.8 (2 x  SDS-PAGE 
sample buffer). Aliquots corresponding  to 50/zg total protein were then 
electrophoresed through 0.1% SDS, 15% polyacrylamide gels, and electro- 
blotted onto nitrocellulose membranes. The membranes were incubated for 
2 h at room temperature with a 1:400 dilution of  rabbit anti-Ran/TC4 antise- 
rum in PBS, pH 7.4, containing 5%  (wt/vol) nonfat dry milk, and 0.3% 
Tween 20. Filters were washed with the same solution (minus antiserum), 
incubated with n5I-protein A (ICN Biomedicals Inc., Costa Mesa, CA) for 
2 h at room temperature, washed with 0.3% Tween 20 in PBS, and autora- 
diographed. 
Digitonin-treated Cell Lysates.  Cells at 50-75% confluence in 10-cm 
dishes were  treated  with  digitonin  in order to  selectively permeabilize 
plasma membranes and release cytosolic components (Adam et al., 1990; 
Shi and Thomas, 1992; Walton et al., 1992). Specifically, cells were washed 
twice in 5 ml ice cold PBS and then incubated for 10 min in ice cold permea- 
bilization  buffer containing  25  /zg/ml digitonin  (Sigma Chem.  Co.,  St. 
Louis, MO),  140 mM KCI, 1 mM MgCI2, and 10 mM sodium phosphate, 
pH 7.0. Permeabilization buffer (containing cytosolic components) was re- 
moved, and cellular material remaining on the plate (including nuclei and 
other major membrane organelles) was solubilized in 1 ml 2 % SDS, 50 mM 
Tris, pH 7.5. The proteins solubilized in the permeabilization buffer were 
precipitated  in 10% ~  and redissolved in 1 ml 2%  SDS, 50 mM Tris, 
pH 7.5. Solubilized proteins from each fraction were then boiled for 10 rain, 
sonicated,  added to equal volumes of 2x  SDS-PAGE sample buffer, and 
analyzed for Ran/TC4 content by the immunoblotting procedures described 
above for total cell lysates. 
Immunoprecipitation 
Cells at 50-75 % confluence in 3.5-cm dishes were washed with methionine- 
free DME, and incubated in 1 mi of the same supplemented with 125 #Ci 
[35S]methionine (1,130 Ci/mmol) for 6 h at 37~  Cells were washed twice 
in PBS, lysed in 0.1 mi 2% SDS, 50 mM Tris, pH 7.5, boiled 10 min, soni- 
cated, and diluted 1:10 in 1.25 % Triton X-100, 150 mM NaC1, 50 mM Tris, 
pH 7.5, 6 mM EDTA (solution A).  Lysates were precleared with protein 
A-Sepharose  beads, incubated for 1 h at room temperature with 1:200 rab- 
bit anti-Ran/TC4 antiserum, and then for 1 h at room temperature with pro- 
tein A-Sepharose. Precipitated beads were washed four times with solution 
A, once with solution A containing 0.5 M NaCI, and once with PBS. Beads 
were then boiled in 50/zl SDS-PAGE  sample buffer, and the eluate was elec- 
trophoresed through a 0.1% SDS, 15% polyacrylamide gel.  The gel was 
fixed for 3 h in 25% methanol,  10% acetic acid, incubated 1 h in autoradi- 
ography enhancer (EN3HANCE; DuPont Co., Wilmington, DE) and 1 h 
in water (all at room temperature),  and then dried and autoradiographed 
(XAR film, Eastman Kodak Co., Rochester, NY). 
Densitometry 
Autoradiograms from Southern and Western blotting experiments were ana- 
lyzed  with  a  GS300  transmittance/reflectance  scanning  densitomcter 
(Hoefer Sci. Instrs., San Francisco, CA) coupled to a computer. Integrated 
absorbances  for each band were recorded as bar graphs. 
Phosphorimaging 
Quantitation of  Western blots to obtain the data shown in Fig. 7 was carried 
out using a Phosphorlmager unit (Molecular Dynamics, Sunnyvale, CA). 
Data are recorded as bar graphs,  in arbitrary  units. 
Immunofluorescence Staining 
Cells on coverslips were washed in PBS, fixed in 3% paraformaldehyde in 
PBS for 10 rain, washed three times in PBS, permeabilized in 0.2% Triton 
X-100 in PBS for 5 rain, washed three times in 3% BSA in PBS, incubated 
with 1:300 anti-Ran/TC4 antiserum or 1:500 anti-RCC1 antiserum (diluted 
in PBS +  3% BSA) for 1 h, washed three times in PBS  +  3% BSA, in- 
cubated  with  FITC-conjugated  goat  anti-rabbit  Ig  antibody  (Cappel 
Laboratories, Maivern, PA; 1:200 in PBS + 3% BSA) for 1 h, washed five 
times  with PBS, and then mounted with an antibleaching agent (FITC- 
Guard;  Testog, Inc.) and examined using an Axiophot microscope (Carl 
Zeiss, Inc.,  Tbornwood, NY) equipped with 40x  (low magnification) or 
63 x  (high magnification) Plan-Neofiuar objective lenses. 
To determine the effects of digitonin treatment, cells were incubated for 
10 rain in ice cold permeabilization buffer, and then fixed and stained as 
described above. 
Transfection Assays 
The plasmids pMT2 (Kaufman, 1990), pRSV-TH  (Rindler et al., 1990), and 
pRSV-CAT (Gorman et al.,  1982) were gifts from Drs. M. Adesnik, M. 
Rindler,  and  G.  Kreibich,  respectively, pMT2  plasmid constructs  were 
propagated in E.  coli strain DH5,~. 
Transfections  were  performed  essentially  as  described  by  Kaufman 
(1990): 10-cm dishes of COS cells at 50-70%  confluence were incubated 
with a total of 8/zg plasmid DNA in 4 nil DEAE-dextran (500/zg/rnl  in 
serum-free DME) for 8 h at 37~  washed once with serum-free DME, in- 
cubated 90  s in serum-free DME  +  10%  DMSO, washed, incubated in 
DME +  10% FCS +  100 ~g/ml chloroquine for 3 h at 37~  washed, and 
incubated for at least 60 h in DME  +10% FCS at 37~ 
Cellular proteins were then examined by SDS-PAGE and stained with 
Coomassie blue. 
Hirt (1967) extracts were prepared by lysing cells for 20 rain at 25~  in 
1 mi 0.6% SDS, 10 mM EDTA, 10 mM Tris, pH 7.5, adding 0.25 ml 5 M 
NaC1, and incubating for 16 h at 4~  Supernatants collected by centrifuga- 
tion (30 rain at 17,000 rpm in a microfuge at 4~  (Eppendorf Inc., Fremont, 
CA) were made 10 ttg/mi in RNase A, incubated I h at 37~  made 20/~g/ml 
in Proteinase K, incubated another hour at 37~  extracted twice with 1:1 
phenol/chloroform and twice with chloroform,  and ethanol precipitated. 
Precipitates  were resuspended and digested  for 2  h at 37~  with 20  U 
EcoRI, ethanol precipitated, resuspended, and digested for 2 h at 37~  with 
20 U DpnI (65 ~tl total volume in each case). One fifth of this material was 
electropboresed  through a  1%  agarose gel,  transferred  to a GeneScreen 
membrane filter (DuPont Co.), and probed with nick-translated 32p-labeled 
pMT2 DNA as described by DuPont Co. 
Chlorampbenicol acetyltransferase assays were performed as described 
by Ausubel et al.  (1989). 
Chromosomal DNA Synthesis  Assays 
COS cells were cotransfected with 4/zg of a pM'I2  construct  encoding 
Ran/TC4  protein  and 4  /~g of plasmid  pRSV-TH, encoding the 1hmm- 
Horsfail  membrane  glycoprotein  (TH) l by  the modified DEAE-dextran 
procedure described above. Cells were then cultured for 72 h, the last 30 
of which were in the presence of  bromodeoxyuridine (DNA replication kit, 
Amersham Corp., Arlington Heights, IL). Cells were washed in calcium- 
free HBSS (cHBSS), detached from culture dishes by a 15-rain incubation 
at 37~  in cHBSS +  10 mM EDTA, collected by centrifugation and washed 
twice in ice-cold cHBSS + 7 % FCS, incubated with 1:100 goat anti-TH pro- 
tein (Cappel Laboratories) for 1 h on ice, washed three times with cHBSS 
+  7%  FCS, incubated with  1:500 FITC-conjugated donkey anti-goat  Ig 
(Jackson Immuno Research Labs., Inc., West Grove, PA) for 1 h on ice, 
washed three times as before, and passed through a 60-/zm nylon mesh. Ap- 
proximately one million filtered cells were subjected to flow sorting (by Dr. 
John Hirst, Kaplan Cancer Center, New York University), and the brightest 
and dullest 5 % of the distribution were recovered as separate fractions and 
sedimented onto slides. The cells were fixed in 95% ethanol,  5% acetic 
acid,  and  stained  with  a  monoclonai  antibromodeoxyuridine  antibody 
(Amersham Corp.)  followed by a phycoerythrin-conjugated donkey anti- 
mouse Ig antibody (Jackson Immuno Research Labs.,  Inc.). 
1. Abbreviations used in this paper: GAP, GTPase activating protein; GDI, 
guanine nucleotide dissociation inhibitor;  GNRP, guanine nucleotide re- 
lease  protein;  MFF,  mitosis/maturation  promoting  factor;  TH,  Tamm- 
HorsfaU membrane glycoprotein. 
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Spll  1  M.,PQNVPT  .............................  I  .......... 
HRAS  1  MTE Y...V..A..  V..SALTIQL IQNH.VDE,D P.IEDSYRKO 
Ran/TC4  51  VFHTNRGPIK FNVUDTAG~E KFGGLRDGYY IQAQCAIIMF DVTSRVTYKN 
Spil  50  H  ....  F.E.C  ...........  L  ..........  G..G  .........  I  .... 
HRAS  44  ,-VIDGETCL LDIL  ......  EYSAM..Q.M RTGEGFLCV.  AINNTKSFED 
Ran/TC4 I01  VPNWHRDLVR VCE -NIPIV LCGNKVDIKD RKVKAKSIVF H-RKKNLQYY 
Spil  I00  ..H.U  ........  --. ...........  V.E  ......  A.T  .......... 
HRAS  93  IHOYREQIK.  .KDSDDV.M.  .V...C.LAA .T.ESROAQD LA.SYGIP.I 
Ran/TC4 148  DISAKSNYNF EKPFLULARK LIGDPNLEFV AMPALAPYEV VMDPALAAQY 
Spil  147  ..................... V.N  .......  S  ........ QV.QQ.L.., 
HRAS  143  ET...TRQGV  .DA,YT.V.E IRQHKLRKLN PPDESG.GCM SCKCV.S  189 
Ran/TC4 198  EHDLEVAQTT ALPDEDD-DL  216 
Spil  197  QQEMNE.AMP -.  .....  A..  215 
Figure 1. Ran/TC4 amino acid sequences. The complete sequence 
predicted  for human and mouse Ran/TC4 is aligned with those 
predicted for S. pombe Spil (Matsumoto and Beach, 1991) and hu- 
man H-R.AS (Barbacid, 1987). Dots indicate residues identical to 
corresponding ones of Ran/TC4; dashes indicate gaps introduced 
to maximize homology. The sequence used to generate an anti- 
Ran/TC4 peptide antibody is underlined. The Ran/TC4 residues al- 
tered in the "double-activated"  mutant construct are indicated with 
asterisks. The corrected human Ran/TC4 eDNA sequence has been 
deposited with GenBank (accession number M31469). 
Results 
Predicted Amino Acid Sequence of  Human and 
Mouse Ran/TC4 
We have resequenced our human Ran/TC4 clone (Drivas et 
al.,  1990) on both strands using internal primers and have 
obtained a  sequence that agrees well with those proposed 
from studies of the human protein (Bischoff and Ponstingl, 
1991a)  and of the homologous S. pombe gene (Matsumoto 
and Beach, 1991), as shown in Fig. 1. Of the 125 amino acid 
residues  determined for the purified human protein,  124 
agree with the sequence predicted for Ran/TC4 (Fig. 1). The 
exception is the nonconservative substitution of Ser (found 
at position 129) for Arg (predicted). Additional indirect sup- 
port for the corrected sequence was provided by the isolation 
and analysis of a mouse testis eDNA clone whose nucleotide 
sequence was 90 % identical to that of Ran/TC4 throughout 
its open reading frame (Hsieh, C.-M., V. Clarke, and M. G. 
Rush, data not shown), and which predicted an amino acid 
sequence  identical  to  the  corrected human  Ran/TC4  se- 
quence. 
Ran/TC4 defines a novel subfamily of Ras-related proteins. 
It shares with H-RAS the four sequence domains that make 
up the guanine nucleotide binding pocket of the latter,  in- 
cluding residues corresponding to H-RAS  codons  12  and 
61,  whose mutations disrupt H-RAS GTPase activity. The 
Ran/TC4  sequence otherwise diverges considerably  from 
that of H-R.AS. Its distinctive features include a highly acidic 
carboxyterminal region that lacks the motifs associated with 
isoprenylation  and  membrane  targeting  characteristic  of 
other RAS-related proteins (Barbacid,  1987;  Drivas et al., 
1991a;  Der and Cox,  1991). 
A  Ran/TC4-specific Antipeptide Antibody 
Previously, antibodies specific for Ran/TC4 have been ob- 
tained only in limited amounts by adsorption from complex 
antisera (Bischoff  and Ponstingl, 1991a).  To generate mono- 
specific antibodies directly, we took advantage of the diver- 
gence of the carboxy-terminal sequence of Ran/TC4 from 
those of other RAS-related proteins to generate polyclonal 
Figure 2. Cellular proteins recognized by anti-Ran/TC4 peptide an- 
tibodies. (A) Western blotting. Total cell lysates (50/~g total pro- 
tein) prepared from 31"3, COS, and HeLa ceils were fractionated 
by SDS-PAGE and analyzed by Western blotting with rabbit anti- 
Ran/'l'C4, or preimmune serum, and 125I-protein  A. Mobilities of 
size standards are indicated. (B) Immunoprecipitation. COS ceils 
were metabolically labeled with [35S]methionine  and lysates were 
incubated with anti-Ran/TC4 antibodies,  or preimmune  serum, 
plus  protein A-Sepharose.  Precipitates  were  analyzed by SDS- 
PAGE and fluorography. 
rabbit antibodies specific for Ran/TC4.  A  hydrophilic do- 
decapeptide, indicated by underlining in Fig. 1, was synthe- 
sized, coupled to Keyhole Limpet hemocyanin, and used to 
immunize rabbits. 
One of two rabbits tested yielded a high-titer, monospecific 
anti-Ran/TC4 antiserum. The antiserum reacted with a sin- 
gle 25-kD band in Western blots of extracts of bacteria and 
monkey cells harboring human Ran/TC4 cDNA in expres- 
sion vectors. (The predicted molecular weight of Ran/TC4 
is 24,423). It also reacted with a single 25-kD band in West- 
ern blots of total cell lysates of untreated mouse (3T3), mon- 
key (COS),  and human (HeLa) cell lines (Fig.  2  A).  The 
same band was visualized in immunoprecipitates of [35S]- 
methionine-labeled  COS  cell  extracts  resolved  by  SDS- 
PAGE (Fig. 2 B). 
When  COS  and  HeLa  cells  were  reacted  with  anti- 
Ran/TC4  antiserum  plus  fluorescently labeled  goat anti- 
rabbit Ig, staining was restricted to the nuclei of interphase 
cells.  Mitotic  cells were diffusely stained  except that  the 
metaphase chromosomes themselves were unstained (Fig. 
3).  Staining  of 3T3  cells  gave  similar  results  (data  not 
shown). 
The absence of Ran/TC4 from metaphase chromosomes 
was confirmed using digitonin-permeabilized COS cells, in 
which most of the cytosol and background Ran/TC4 was re- 
moved (Fig. 4). Permeabilized mitotic cells were essentially 
unstained  with  anti-Ran/TC4,  while  metaphase  chromo- 
somes  continued to be  stained  with  anti-RCC1.  Approxi- 
mately 10 metaphases were examined with each antibody. 
Dependence of the Nuclear Localization of  Ran/TC4 
on RCC1 Expression 
Because of the genetic and in vitro biochemical evidence of 
interaction between Ran/TC4 and RCC1/Piml (Bischoff and 
Ponstingl, 1991a,b; Matsumoto and Beach, 1991), we asked 
whether the nuclear localization of Ran/TC4 is dependent on 
the presence of RCC1 in vivo. In the BHK cell line BHK21, 
Ran/TC4 and RCC1 proteins, as detected by immunofluores- 
cence microscopy, were localized to cell nuclei at both 33.5 
and 39.5~  (data not shown). The cell line tsBN2, a mutant 
derived from BHK21,  synthesizes a  temperature-sensitive 
RCC1 protein. Within 3 h of  transfer from 33.5~  to the non- 
permissive temperature of 39.5~  immunologicaUy detect- 
Ren et al. Ran/TC4, A Nuclear RAS-related  Protein  315 Figure 3. Nuclear localization of  Ran/TC4. COS and HeLa  cells were fixed, permeabilized, stained with rabbit anti-Ran/TC4, or preirmmune 
serum, plus FITC-conjugated goat anti-rabbit Ig, and photographed under phase contrast or epiiUumination. Arrows indicate mitotic cells. 
able RCC1 in tsBN2 cells was greatly reduced (Figs. 5 and 
7),  a  change which can be reversed only by returning the 
cells to the lower temperature and allowing new protein syn- 
thesis (Uchida et al., 1990; Nishitani et al., 1991). When we 
stained tsBN2 cells grown at 33.5~  with anti-Ran/TC4 anti- 
body or with anti-RCC1 antibody, fluorescence was localized 
to cell nuclei (Figs. 5 and 6-0 h). When tsBN2 cells were 
incubated for 3-6 h at 39.5~  however, RCC1 was no longer 
Figure 4,  Localization of Ran/TC4 and RCC1 in digitonin-permeabilized  COS cells. Cells were permeabilized,  fixed, and stained with 
anti-Ran/TC4 or anti-RCC1. Arrows indicate mitotic cells. 
The Journal of Cell Biology,  Volume 120, t993  316 Figure 5.  Subcellular localization of Ran/TC4 and RCC1 in tsBN2 cells-low magnification. Cells incubated for 0, 3, or 6 h at 39.5~ 
were fixed, permeabilized, and scored for Ran/TC4 and RCC1 localization as described in the legend to Fig. 3. DNA was localized by 
staining with HOECHST 33258  (Flow Labs., McLean, VA). 
Ren et al. Ran/TC4, A Nuclear RAS-related Protein  317 Figure 6. Subcellular localization of Ran/TC4 in tsBN2 Cells-high magnification. Cells incubated for 0, 3, or 6 h at 39.5~  were fixed, 
permeabilized, and scored for Ran/TC4 localization as described in the legend to Fig. 5. 
detectable and substantial  Ran/TC4 staining of cytoplasm 
was detected (Figs. 5 and 6). Visual scoring of photographs 
such as those shown in Fig. 5 indicated that at least 90 % of 
cells exhibited Ran/TC4 cytoplasmic staining after a 3-h in- 
cubation at 39.50C.  Total cellular levels of Ran/TC4 protein 
were essentially unchanged over the course of these experi- 
ments in both tsBN2 and BHK21 cells (Fig. 7). 
The release of Ran/TC4 from the nuclei of tsBN2 cells at 
39.5~  was analyzed more quantitatively by using immuno- 
blotting to measure the fraction of Ran/TC4 present in cyto- 
solic extracts of digitonin-permeabilized cells. As shown in 
Fig. 7, the total amount of Ran/TC4 remained constant over 
6 h at 39.5~  but the fraction of this protein extracted by 
digitonin treatment increased from 19 to 55 %. This redistri- 
bution of Ran/TC4 was specific to tsBN2 cells, as the frac- 
tion of Ran/TC4 released from normal BHK21 ranged be- 
tween 10 and 15 % over 6 h at 39.5~  Both immunostaining 
and cellular fractionation procedures thus demonstrate that 
a significant fraction of Ran/TC4 protein is released from the 
nuclei of tsBN2 cells at 39.5~ 
Neither cell death nor increased entry into mitosis at the 
nonpermissive temperature is sufficient to explain the redis- 
tribution of Ran/TC4 into the cytoplasm, tsBN2 cells exhibit 
normal RNA and protein synthesis for at least 12 h at 39.50C 
(Nishimoto et al., 1978). Also, after 6 h at 39.5~  no more 
than 5 % of unsynchronized tsBN2 cells exhibit a mitotic ap- 
pearance (Fig. 5), consistent with the previous observation 
that  after 6  h  at  39.5~  tsBN2  cells are  arrested  in  G1 
(Nishimoto et al.,  1978;  Nishitani  et al.,  1991),  Most of 
these cells would have been in G1 at the time of the tempera- 
ture shift and would have arrested there; the minority in S 
or G2 would be expected to progress through M  to arrest 
in G1. 
Effect of a Putative GTPase-deficient Mutant Ran/TC4 
on Cellular DNA Synthesis 
Members of the GTPase superfamily, including translation 
factors,  heterotrimeric  G  proteins,  and  RAS  and  RAS- 
related proteins, function as switches, changing state accord- 
ing to the nucleotide, GTP or GDP, bound to the GTPase. 
Ran/TC4 is known to bind and hydrolyze  GTP, and exchange 
of bound GDP for GTP is accelerated by interaction with 
RCC1 (Bischoff  and Ponstingl, 1991b). We have therefore ex- 
amined the functional consequences in vivo of transient ex- 
pression of wild-type and mutated forms of the gene in COS 
ceils. 
The  human  Ran/TC4  eDNA  was  mutated  in  vitro  to 
specify Val at codon 19 (equivalent to H-RAS codon 12) and 
Leu at codon 69 (equivalent to H-RAS codon 61).  In previ- 
ously studied RAS and RAS-related proteins, these substitu- 
tions  alone  or  in  combination  cause  GTPase  deficiency 
(Bourne et  al.,  1991;  Kaziro  et  al.,  1991).  The double- 
mutant and wild-type cDNAs were cloned into the pMT2 ex- 
pression vector, which contains the SV-40 origin of replica- 
tion. These constructs were transfected into COS ceils, and 
protein products in cell extracts prepared 48-70 h after trans- 
fection were analyzed by SDS-PAGE. This system should al- 
low transient expression of large amounts of any protein en- 
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F/gure 7. Quantitation of Ran/~4 and RCCI in tsBN2 and BHK21 
Ceils.  (A) BHK2I  and tsBN2 cells incubated for 0, 3, or 6 h at 
39.5~  were analyzed  for total Ra~/TC4 and RCC1 proteins by im- 
munoblotting and  phosphorimaging. The  bar  graphs  show the 
results of phosphorimaging in arbitrary  units. (B)  BHK21 and 
tsBN2 cells incubated for 0, 3, or 6 h at 39.5~  were treated with 
digitonin to generate cytosolic and residual fractions and the per- 
centage of Ran/TC4 extracted in the cytosolic fraction was deter- 
mined by immunoblotting and phosphorimaging. 
coded by the construct. Vector copy number should be high 
because the SV-40 replication origin in the vector interacts 
with T antigen produced by the COS cell host to generate 
hundreds of thousands of plasmid copies over the period of 
the experimem (Mellon et al.,  1981),  and gene expression 
should be efficient because the vector contains strong tran- 
scription promoters  and translation enhancers  (Kaufman, 
1990). 
COS cells transfected with the wild-type Ran/TC4 eDNA 
insert produced an abundant 25-kD polypeptide, visualized 
by Coornassie blue staining and measured by densitometric 
analysis of Western blots.  Cells transfected with the Ran/ 
TC4 double-mutant construct likewise yielded novel protein, 
but at 10% of  the wild-type level (Fig. 8). This inhibition was 
also observed"m trans': when COS ceUs were commuted 
with pMT2-Ran/TC4 mutant constructs plus pMT2 constructs 
harboring dihydrofolate reduetase, YL8 (a human homolog 
of the S.  pombe YPT-3  RAS-related gene;  Drivas et al., 
1991b),  or cytochrome 1)450, the latter proteins were pro- 
duced at 10% of  the levels observed in cotransfection experi- 
ments with wild-type Ran/TC4 constructs (Fig. 8 and data 
not shown). 
Inhibition was a specific property of Ran/TC4 mutant con- 
structs.  COS cells transfected with pMT2 constructs con- 
tairting the RAS-related eDNA clones TC10 or TC21 (Drivas 
et  al.,  1990),  YL8,  and  five  YL8  mutants  (including 
Figure 8.  Proteins made in COS cells transfected with Ran/TC4 
gene constructs. (A) SDS-PAGE. COS cells were transfected with 
(1) nothing (mock); (2) pMT2-DHFR, which specifies an '~22 kD 
protein; (3) pMT2-wild type Ran/TC4, which specifies  an '~25 kD 
protein; (4) pMT2-mutant Ran/TC4; (5) equal amounts of pMT2- 
DHFR and pMT2-wild-type Ran/TC4; and (6) equal amounts of 
pMT2-DHFR and pMT2-mutant Ran/TC4. Cultures were har- 
vested 62 h after transfection and analyzed by SDS-PAGE and 
Coomassie blue staining. (B) Western blotting, Total cell lysates 
(50/+g protein) prepared from each of the transfected cell popula- 
tions (lanes 1-6) were analyzed by Western blotting as described 
in the legend to Fig. 2 A. The bar graph shows  the results of  densito- 
metric analysis of the Western blot, in arbitrary units. 
GTPase-  ones)  all  produced high. levels  of the  expected 
proteins (Zeng, J., and M. Ren, unpublished observations). 
This reduction was due to failure of the transfected plas- 
mids to replicate. Specifically, to demonstrate that transcrip- 
tion and translation of plasmid genes was normal, pMT2- 
Ran/TC4  mutant  was  cotransfected  into  COS  cells  with 
plasmid constructs whose product could be detected in the 
absence of plasmid replication, pRSV constructs encoding 
TH, ~galactosidase, or chloramphenicol acetyltransferase 
programmed the synthesis of proteins that could be detected 
even at low levels by immunofluorescence, ~galactosidase 
enzymatic activity, or chloramphenicol acetyltransferase as- 
say, respectively. Equal levels of  the products, as determined 
by densitometric analysis, were detected in COS cells trans- 
fected with the pRSV construct alone or with the pRSV con- 
struct plus pMT2-Ran/TC4 mutant (data not shown). 
To show directly that the pMT2-Ran/TC4 mutant product 
blocked plasmid DNA replication, parallel cultures of COS 
cells were transfected with bacterially methylated pMT2- 
Ran/TC4  wild-type  and  mutant  constructs.  Supernatants 
prepared 60 h after transfection (Hirt,  1967) were digested 
with EcoRI (to linearize all plasmid molecules) plus DpnI 
(to digest methylated, hence unreplicated, DNA into multi- 
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sation of DNA replication: cell populations. Supematants (Hirt, 
1967) from COS cells transfected with pMT2 constructs as de- 
scribed in Fig. 8 were analyzed by Southern blotting. Cells were 
transfected with nothing (mock), pMT2-DHFR, pMT2-wild-type 
Ran/TC4, pMT2-mutant  Ran/TC4, equal amounts of  pMT2-DHFR 
and  pMT2-wild-type Ran/TC4, and  equal  amounts of pMT2- 
DHFR and pMT2-mutant  Ran/TC4. The two leftmost  tracks on the 
gel are loaded with 300- and 10-rig quantities of pure methylated 
pMT2 plasmid processed in parallel with the Hirt supernatants but 
digested only with EcoRI. The bar graph shows  the results of den- 
sitometric analysis of the blot. Amounts of fragment in each track 
were calculated relative to the  intensity of the 300-ng control 
fragment. 
ple  small  fragments) and analyzed by  Southern blotting. 
pMT2 DNA recovered as a large fragment (hence replicated 
after  transfection)  was  reduced  *10-fold  in  extracts  of 
mutant-transfected cells relative to cells transfected with the 
wild-type construct (Fig. 9). 
To ask whether the mutant Ran/TC4 gene product would 
suppress host chromosomal DNA replication, we devised a 
FACS  |  assay to  correlate expression of transfected genes 
with levels of DNA synthesis on a cell-by-cell basis.  COS 
ceils were cotransfected with pMT2-Ran/TC4 mutant plus 
pRSV-TH membrane protein and cultured at 37~  for 72 h. 
To  assay  replication  of  host  cell  chromosomal  DNA, 
bromodeoxyuridine was added to the growth medium for the 
last 30 h of the culture period. Single cell suspensions were 
then stained with anti-TH antibody. FACS  |  analysis yielded 
populations of TH  § cells (transfected-•25  % of the total 
population) and TH- cells  (untransfected- *75 %).  These 
were  collected  and  stained  with  antibromodeoxyuridine 
(Fig.  10).  Most TH- cells had incorporated bromodeoxy- 
uridine, while most TH  § cells had not. That is, presence of 
the Ran/TC4 mutant construct in a  COS  cell blocked its 
DNA replication. Transfection of other plasmids into COS 
cells, including pMT2-Ran/TC4 wild type, had no effect on 
bromodeoxyuridine incorporation. This result demonstrates 
a  role  for  Ran/TC4  protein  in  either  mammalian chro- 
mosomal DNA replication, cell cycle progression, or both, 
and confirms that the plasmid results are not an artifact due 
to averaging or to the specific replication properties of our 
transfected plasmids. 
Discussion 
Ran/TC4 is a remarkably well-conserved member of the RAS 
supergene family, specifying proteins of identical sequence 
in humans and mice and 80 % identical between these species 
and  S.  pombe  (Fig.  1).  Using  a  dodecapeptide  from its 
carboxy-terminal region, high-titer, monospecific polyclonal 
antibodies to Ran/TC4 were readily obtained (Figs. 2 and 3). 
Immunostaining experiments showed that Ran/TC4 is pri- 
marily restricted to the nuclei of interphase cells, and is 
diffusely distributed in mitotic cells (but excluded from the 
chromosomes). These staining patterns are consistent with 
the ones reported by Bischoff  and Ponstingl (1991a) for anti- 
bodies extracted from a complex antiserum by adsorption to 
purified Ran/TC4 protein. 
Ran/TC4 protein has been suggested to interact with RCC1 
protein. As a structural correlate of that interaction, we have 
shown that  nuclear localization of Ran/TC4  requires  the 
presence of functional RCC1 protein (Figs. 5 and 6). The nu- 
clear localization of Ran/TC4 and RCC1 is intriguing in two 
respects. First, although the amino-terminal DNA binding 
domain of RCC1  functions as a nuclear localization signal 
(Seino  et  al.,  1992),  neither  protein  includes  clearly 
identifiable nuclear localization signals such as the stretches 
of arginine and lysine residues found in many nuclear pro- 
teins (Fig.  1;  Bischoff et al.,  1990;  Garcia-Bustos et al., 
1991). Second, while RCC1 protein is required to maintain 
the nuclear localization of Ran/TC4, the cellular molar ratio 
of Ran/TC4 to RCC1  is at least 10:1 and Ran/TC4.RCC1 
complexes in vitro contain a  1:1 protein ratio (Bisehoff and 
Ponstingl, 1990,  1991a).  RCC1 must therefore be modulat- 
ing the nuclear localization of Ran/TC4 by mechanisms in 
addition to simple binding. 
A Ran/TC4 mutant homologous to GTPase-defective H-RAS 
(Fig. 1) was constructed. When plasmids containing the mu- 
tant construct were transfected into COS cells, replication of 
the plasmid was blocked, as was replication of any cotrans- 
fected plasmid and replication of the host cell chromosomes 
(Figs. 8-10). The blockade appears to be replication specific, 
as transcription and translation of plasmid genes were not 
detectably affected. A crucial problem that remains unsolved 
is to identify  the point(s) in the cell cycle at which cells arrest 
in response to mutant RardTC4 protein. Data from the ex- 
periments reported here are consistent with arrest at the GI/S 
boundary or in S caused by a direct effect  of  the Ran/TC4 mu- 
The Journal  of Cell Biology,  Volume 120, 1993  320 Figure 10. Correlation of transfection with mutant RardTC4 and cessation of DNA replication: single cells. COS cells cotransfected with 
pMT2-mutant Ran/TC4 plus plasmid pRSV-TH, encoding the TH membrane protein, were cultured for 72 h, the last 30 of which were 
in the presence of  bromodeoxyuridine.  Transfected  and untransfected  cells were resolved by flow  sorting after staining with anti-TH  antibod- 
ies, and DNA replication in each population was assayed by sedimenting cells onto slides, permeabilizing them, and staining with an- 
tibromodeoxyuridine antibodies. Two representative fields of each cell population are shown. 
tant on DNA synthesis, but arrest elsewhere in the cell cycle 
cannot be excluded. Extension of  the FACS  |  analysis of  COS 
cells to measure DNA content was uninformative because 
the cells are heterogeneous and polyploid. Resolution of  this 
issue will probably require studies of uniformly diploid cell 
populations. 
A Hypothetical GTPase  Switch Using  Ran/TC4 and 
RCC1 to Monitor the Progress of  DNA Replication 
Guanine nucleotide binding proteins, whether they are true 
RAS proteins, members of the YPT/Rab subfamily involved 
in vesicle sorting, heterotrimeric G proteins, or protein syn- 
thesis initiation and elongation factors, function as switches 
whose GTP- and GDP-bound forms interact differentially 
with effectors and regulators (Bourne et al., 1990; Kaziro et 
al.,  1991). Most guanine nucleotide binding proteins have 
low intrinsic rates  of GTP hydrolysis and nucleotide ex- 
change, so that the functional state of the switch is regulated 
by associated proteins that increase GTPase activity (GTP- 
ase activating proteins, or GAPs), and that inhibit or pro- 
mote turnover of bound nucleotide (guanine nucleotide dis- 
sociation inhibitors,  or GDIs,  and guanine nucleotide re- 
lease proteins, or GNRPs, respectively). For example, in the 
case of the bacterial protein synthesis elongation factor EF- 
TU, EF-TU-GTP binds to aminoacyt-tRaNA, GAP and GDI 
activities are associated with the ribosome, and GNRP activ- 
ity is provided try EF-TS. In the case of eukaryotic vesicle 
sorting,  (G.GDP).GDI  complexes  appear  to  be  soluble, 
while GNRP and GAP activities may be associated with do- 
nor or acceptor membranes (for review see Pfeffer,  1992). 
By analogy to these systems, models can be constructed 
in which Ran/TC4.RCC1 monitors the progress of  DNA syn- 
thesis and couples the completion of DNA synthesis to the 
activation of mitosis/maturation promoting factor (MPF). 
MPF is a complex of two proteins, a cyclin and a  serine- 
threonine protein kinase p34  cDc2 (for review see Freeman 
and Donoghue, 1991). MPF plays a key role in cell cycle con- 
trol in all eukaryotes. Its regulation involves complex inter- 
actions among tyrosine and serine-threonine protein kinases, 
protein phosphatases, a cyclin protease, and other activators 
and inhibitors.  MPF activation, required in prophase,  in- 
volves at least cyclin-p34  c~::  complex formation, cyclin 
phosphorylation, and activation of p34  cDc2 kinase via re- 
moval of esterified phosphate from a tyrosine residue. MPF 
inactivation, in anaphase, requires destruction of cyclin. 
Two alternative models that both use RCC1 as a monitor 
of the completion of DNA synthesis, and that couple the cell 
cycle and a GTPase cycle involving RardTC4 and RCC1 are 
shown in Fig. 11. The models differ in the timing of GNRP 
and GAP activities and in the role of RardTC4.GTP as either 
an inhibitor or activator of MPE Thus, in the upper model, 
START (the beginning of DNA synthesis or a  signal that 
commits the celt to DNA synthesis) activates a GNRP ac- 
tivity,  possibly  RCC1,  that  stimulates  the  conversion  of 
Ran/TC4 to its GTP-botmd state, which in turn inhibits MPF 
activity. FINISH (a signal such as the elimination of single- 
stranded DNA or the disassembly of replication complexes 
that indicates the completion of DNA synthesis) attenuates 
GNRP activity, activates GAP, and thus sharply reduces the 
concentration of Ran/TC4.GTP. This in turn releases the in- 
hibition of MPF. In the lower model, START activates GAP, 
FINISH activates GNRP, and Ran/TC4.GTP both stimulates 
MPF activation and directly irdfibits DNA replication. A key 
feature  of  the  lower  model  is  the  autoregulation  of 
Ran/TC4.GTP function through the activation of a GDI that 
binds to RanlTC4.GTP and prevents the further activation 
of MPF. 
Our demonstration that expression of putative GTPase- 
defective Ran/TC4 protein inhibits DNA synthesis is consis- 
tent with either of these models. 
In regard to the mechanism of  MPF activation, our models 
predict that the unreplicated DNA present between START 
and FINISH alters levels of Ran/TC4-GTP.  We speculate 
that this change is an essential step of a pathway that leads 
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a  GTPase cycle through the nuclear proteins Ran/TC4 and RCC1. 
GAP and GDI are as-yet-unidentified proteins hypothesized to in- 
teract specifically with Ran/TC4 to promote GTP hydrolysis, and 
to inhibit effector interaction and nucleotide exchange, respectively. 
START and FINISH mark the beginning and end of DNA replica- 
tion. GNRP activity appears to be provided by RCC1. In the lower 
model, (-)  indicates the direct inhibitory effect of Ran/TC4.GTP 
on DNA synthesis and (+) indicates the release of this inhibition. 
Ran/TC4  is abbreviated simply as TC4  here. 
to MPF inactivation,  although there may be multiple inter- 
mediate steps. For example, considering the upper model of 
Fig.  11,  Ran/TC4.GTP  could stimulate,  either  directly or 
through regulatory kinases and phosphatases,  the activation 
of the kinase that phosphorylates p34CDC2 on tyrosine, thus 
inactivating  MPF  (Smythe  and  Newport,  1992).  Ran/ 
TC4.GTP could also inhibit, either directly or indirectly, the 
tyrosine phosphatase  that dephosphorylates p34  c~2 and is 
required for MPF activation (Millar and Russell,  1992). Fi- 
nally, since the induction of premature chromosome conden- 
sation in tsBN2 cells at 39.5~  requires new protein synthe- 
sis (Uchida et al.,  1990), the possibility that Ran/TC4 might 
regulate the synthesis of cell cycle control proteins cannot be 
excluded. 
These models draw on results from both yeast and mam- 
malian  systems.  There  are  important  differences between 
these systems, however, piml ts mutants of yeast under non- 
permissive  conditions  undergo  chromosome  condensation 
from any phase of the cell cycle (G1, G2, or S) and cells ar- 
rest with condensed chromosomes (Matsumoto and Beach, 
1991). In hamster cell RCC1 ts mutants under nonpermissive 
conditions, only cells in S and G2 proceed to chromosome 
condensation and mitosis,  and cell arrest occurs at a point 
in G1 possibly analogous to the "start" point of the yeast cell 
cycle (Nishitani  et al.,  1991).  The  reasons  for the yeast- 
hamster differences are unknown and may be specific to the 
mutant alleles studied in each species. The differences, how- 
ever, do not alter the conclusions that RCC1 and Ran/TC4 
play key roles in the orderly progression of the phases of the 
cell cycle. 
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